All I'm pointing out is that it is the same product between aGVHD, Covid-19 and Temcell - hence, the batch to batch consistency applies to all.
Now stem cell is not a drug, so we can't really discuss the active ingredient - I'll leave that with @dolcevita
The FDA did not discuss this, they've raised issues regarding the MOA, so my question still stand - do the FDA completely the MOA of all the drugs that they have approved?
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-286
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 72752 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 205100 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |